Gastric TNF-α level was further reduced by NS-398 as compared to NPW-treated ulcer group (p < 0.05), while gastric IL-1β levels were depressed more with both of the specific COX-inhibitors (p < 0.05–0.01). This evidence concerns the gene TNF and ulcer disease.